# C3orf20

## Overview
C3orf20 is a gene located on chromosome 3 that encodes the protein known as chromosome 3 open reading frame 20. This protein is currently not well-characterized in terms of its specific biological function or classification into a known protein category such as kinase or receptor. However, genetic studies have suggested that variations in the C3orf20 gene may have significant implications for human health. Notably, certain single nucleotide polymorphisms (SNPs) in C3orf20 have been associated with differences in postoperative analgesic requirements, indicating a potential role in pain perception and management (Nishizawa2022Associations). Additionally, C3orf20 has been implicated in a recessive syndrome involving intellectual disability and muscle weakness, although its precise contribution to this condition remains to be elucidated (Kariminejad2015Intellectual). These associations underscore the importance of further research to fully understand the gene's function and its impact on human health.

## Clinical Significance
The C3orf20 gene has been implicated in various clinical conditions due to its genetic variations and expression levels. A study by Nishizawa et al. identified a significant association between the rs12496846 SNP in the C3orf20 gene and postoperative analgesic requirements. Carriers of the G allele of this SNP required higher amounts of opioids after major surgeries, suggesting that this genetic variation may influence opioid sensitivity and analgesic needs (Nishizawa2022Associations). The G allele was also linked to lower mRNA expression of the C3orf20 gene in the brain, particularly in the anterior cingulate cortex, which may contribute to individual differences in pain management (Nishizawa2022Associations).

In another study, the C3orf20 gene was included in a candidate locus identified in three siblings with a newly described recessive syndrome characterized by intellectual disability, muscle weakness, and distinct facial features. Although the specific role of C3orf20 in this syndrome was not detailed, it was among the 57 genes located in the identified homozygous region on chromosome 3p24.3-p25.3, suggesting a potential involvement in the observed phenotype (Kariminejad2015Intellectual). These findings highlight the potential clinical significance of C3orf20 in both pain management and genetic syndromes.

## Interactions



## References


[1. (Nishizawa2022Associations) Daisuke Nishizawa, Makoto Nagashima, Shinya Kasai, Junko Hasegawa, Kyoko Nakayama, Yuko Ebata, Ken-ichi Fukuda, Tatsuya Ichinohe, Masakazu Hayashida, and Kazutaka Ikeda. Associations between the c3orf20 rs12496846 polymorphism and both postoperative analgesia after orthognathic and abdominal surgeries and c3orf20 gene expression in the brain. Pharmaceutics, 14(4):727, March 2022. URL: http://dx.doi.org/10.3390/pharmaceutics14040727, doi:10.3390/pharmaceutics14040727. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/pharmaceutics14040727)

[2. (Kariminejad2015Intellectual) Ariana Kariminejad, Shahriar Nafissi, Yalda Nilipoor, Alireza Tavasoli, Paul P. Van Veldhoven, Carine Bonnard, Yeng Ting Ng, Charles B. Majoie, Bruno Reversade, and Raoul C. Hennekam. Intellectual disability, muscle weakness and characteristic face in three siblings: a newly described recessive syndrome mapping to 3p24.3–p25.3. American Journal of Medical Genetics Part A, 167(11):2508–2515, July 2015. URL: http://dx.doi.org/10.1002/ajmg.a.37248, doi:10.1002/ajmg.a.37248. This article has 7 citations.](https://doi.org/10.1002/ajmg.a.37248)